ALIVUS LIFE SCIENCES
Back to Balance Sheet
|
ALIVUS LIFE SCIENCES Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹757 Cr | ₹67 Cr | ₹33 Cr | ₹23 Cr | ₹16 Cr |
What is the latest Total Non-Current Liabilities ratio of ALIVUS LIFE SCIENCES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹757 Cr |
Mar2023 | ₹67 Cr |
Mar2022 | ₹33 Cr |
Mar2021 | ₹23 Cr |
Mar2020 | ₹16 Cr |
How is Total Non-Current Liabilities of ALIVUS LIFE SCIENCES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹757 Cr | 1,023.14 | |
Mar2023 | ₹67 Cr | 106.11 | |
Mar2022 | ₹33 Cr | 42.87 | |
Mar2021 | ₹23 Cr | 39.15 | |
Mar2020 | ₹16 Cr | - |
Compare Total Non-Current Liabilities of peers of ALIVUS LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALIVUS LIFE SCIENCES | ₹12,596.5 Cr | -2.7% | 3.2% | 19.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
ALIVUS LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALIVUS LIFE SCIENCES | -2.7% |
3.2% |
19.9% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses